Is there an interest in repeating the vaginal administration of dinoprostone ( Propess ) , to promote cervical ripening of pregnant women at term?
Latest Information Update: 30 Aug 2024
At a glance
- Drugs Dinoprostone (Primary) ; Oxytocin
- Indications Labour induction
- Focus Therapeutic Use
- Acronyms RE-DINO
Most Recent Events
- 23 Jun 2022 Status changed from recruiting to discontinued.
- 21 May 2022 This trial has been discontinued in France according to European Clinical Trials Database record.
- 11 Dec 2020 Planned End Date changed from 9 Jan 2022 to 9 May 2022.